Expert views: 9 stocks that you can buy now

Moneycontrol Bureau

After being rangebound for a long time, the Nifty moved up a little bit yesterday. It closed above the 5,600 market. The Parliament winter session will flag off today. The market might just be focused on some of the local cues. Moneycontrol brings to you some of the recommendations given by experts that will help you cash in on the many opportunities available.

Winter session of Parliament: What are brokerages expecting

Stock picks for today:

Sudarshan Sukhani, s2analytics.com has a 'buy' call on Axis Bank. “It is on the verge of a breakout. If the Nifty shows any signs of cheer, this should be an outperformer,” he elaborates.

Hindustan Unilever has been Sukhani's favourite. "HUL is going to be one of the major components in the rally," he adds.

Sukhani is bullish on Asian Paints. "It is a buy on dips strategy. A buy on dips is always a low-risk strategy. It has been an outperformer and this could continue for a long time," he asserts.

Sukhani is also betting on Zee Entertainment. "It is showing signs of developing a bullish pattern. That breakout is a little away. It is a buy on dips idea," he adds.

Multibagger ideas:

SP Tulsian, sptulsian.com has picked up Birla Corporation and Orbit Corporation as his multibaggers.

Tulsian is seeing Birla Corporation share as a very good investment. "From a short-term point of view of about six months, I am expecting the share to move to Rs 350. In the long-term, 12-18 months, one can also expect to see a price of Rs 450," he adds.
 
Orbit Corporation may see a price of about Rs 70 in the next six months. "My positive stance remains on the realty sector and especially more on the Mumbai real-estate stocks," he adds.

Brokerage calls.

Macquarie has an 'outperform' on Mphasis with a target of Rs 415. The fall in the stock price yesterday was uncalled for as interactions with the management indicate the company has held on to its pricing during its annual price renegotiations with HP.

Morgan Stanley has an 'overweight' on Cipla with a target of Rs 437. The Cipla Medpro deal will help the company to reduce its high dependence on its partners for international marketing and sales.

Macquarie has an 'outperform' on Coal India with a raised target of Rs 450. Their revised growth plan, which forecasts 7% volume growth, could lead to a doubling of profits in four years. Separately, Coal India can resort to a 10% equity buyback which can add 5-6% to EPS, if done at Rs 400 a share.

Deutsche Bank has downgraded Dabur to a 'sell' with a target of Rs 110. Dabur has underperformed the FMCG index by 30% due to poor volume growth and a slowing earnings growth trajectory in the domestic business. The hair oil and international business remain in a declining revenue growth trajectory.

Vini Amesar.
vini.amesar@network18online.com